经济观察报记者刘晓诺北京时间5月31日晚,康方生物(09926.HK)的一份最新数据刷屏了医药人的朋友圈。数据显示,PD-1/VEGF双抗(依沃西)联合化疗,战胜了PD-1联合化疗。有投资界人士兴奋地说,“这次不光是世界杯决赛赢了,而且是大比分打败巴西、阿根廷和西班牙。”此时,康方生物在芝加哥万众瞩目。这份叫HARMONi-6的研究数据,成为首个登陆美国临床肿瘤学会(ASCO)年会全体会议的中国原...
Source Link经济观察报记者刘晓诺北京时间5月31日晚,康方生物(09926.HK)的一份最新数据刷屏了医药人的朋友圈。数据显示,PD-1/VEGF双抗(依沃西)联合化疗,战胜了PD-1联合化疗。有投资界人士兴奋地说,“这次不光是世界杯决赛赢了,而且是大比分打败巴西、阿根廷和西班牙。”此时,康方生物在芝加哥万众瞩目。这份叫HARMONi-6的研究数据,成为首个登陆美国临床肿瘤学会(ASCO)年会全体会议的中国原...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.